Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Eisai, Immvira, Impact, Kelun-Biotech, Mabwell, Tramscenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascentage, Biomx, Celltrion, Enlivex, Junshi, Kelun-Biotech, Renalys.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Jyong Biotech, Lynk, Innovent.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Shilpa Medicare.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alebund, Carsgen, GC Biopharma, Hengrui, Hope Medicines, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Innocare, Innovent, Lumosa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Advancell Isotopes, Astellas, Entera Bio, Harbour Biomed, Iaso Biotherapeutics, Metis Techbio, Rapt Therapeutics, Sagimet Biosciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adocia, Clover, Hutchmed, Iregene, Mabwell, Vor Bio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Carsgen, HEnlius, Hope, Ono, Ribomic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Kazia, Mindrank, Radiopharm.